Searchable abstracts of presentations at key conferences in endocrinology

ea0056p1192 | Thyroid cancer | ECE2018

Tyrosine kinase inhibitors in iodine-refractory thyroid cancer. Clinical experience

Marijuan Clara , Pla Begona , Aguirre Nerea , Fernandez Elena , Hernando Inigo , Jimenez Sara , Marazuela Monica , Lahera Marcos

Introduction: Tyrosine kinase inhibitors (TKIs) are used for treatment of iodine-refractory differentiated thyroid cancer (DTC) in patients with progressive advanced disease.Sorafenib and lenvatinib are the TKIs currently approved for this indication.Objective: To describe the clinical experience in patients with iodine-refractory DTC treated with TKIs in our Institution.Materials and methods: Restrospective cohort study of patient...

ea0081p563 | Calcium and Bone | ECE2022

Analysis of bone mass and body composition in transgender men at 1 year : a follow up study

Mazoca Orozco Bruno Marcos , De Oliveira Otavio Lima , Magliari Haddad Joao Victor , Santos Livia Marcela , Alvares Leonardo

Introduction: Sex steroid hormones play a key role in bone health, however medical therapies for gender dysphoria lead to hormonal changes.Purpose: Understanding the change in bone mass and body composition is extremely important, because this treatment will be carried out over a long period of timeMethods: In a prospective study, we included 19 transgender men (female-to-male trans persons) before treatment and after 1 year of tre...

ea0081ep821 | Pituitary and Neuroendocrinology | ECE2022

Preference of acromegaly patients for treatment attributes in Spain

Fajardo-Montanana Carmen , Alvarez Escola Cristina , Biagetti Betina , Centeno Rogelio Garci a , Ciriza Raquel , Sanchez Laura , Diaz Marcos

Background: Acromegaly is a slowly progressive rare disease caused by an increase in growth hormone secretion that causes a subsequent rise in insulin-like growth factor (IGF-1), both contributing to the excessive growth of the extremities, soft tissues and organs, in addition to other comorbidities directly interfering with patient’s quality of life. Acromegaly patients are concerned about their disease and their treatments, however, publications about patient’s opi...

ea0032p145 | Calcium and Vitamin D metabolism | ECE2013

Experience in the treatment of primary hyperparathyroidism with cinacalcet: data after 12 months of treatment

Luque-Fernandez Ines , Garcia-Martin Antonia , Luque-Pazos Alessandra , Sastre-Marcos Julia , Vicente-Delgado Almudena , Marco-Martinez Amparo , Canovas Barbara

Introduction: Cinacalcet is an oral calcimimetic indicated in treatment of primary hyperparathyroidism if patients do not accept surgery, do not carry out the surgical criteria, there is failure of previous surgery or serious comorbidity that makes surgery impossible.Methods: Descriptive study that included 20 patients with primary hyperparathyroidism who had complete at least 12 months of treatment with cinacalcet for different reasons (eight patients r...

ea0029p265 | Calcium & Vitamin D metabolism | ICEECE2012

Experience in the treatment of primary hyperparathyroidism with cinacalcet: Preliminary data

Luque-Fernandez I. , Garcia-Martin A. , Luque-Pazos A. , Sastre-Marcos J. , Marco-Martinez A. , Vicente-Delgado A. , Pena-Cortes V.

Introduction: Cinacalcet is an oral calcimimetic indicated in treatment of primary hyperparathyroidism if patients do not accept surgery, do not carry out the surgical criteria, there is failure of previous surgery or serious comorbidity that makes surgery impossible.Methods: Descriptive study that included 34 patients with primary hyperparathyroidism treated with cinacalcet. We recorded clinical and biochemical data before and after 6 months of treateme...

ea0056p255 | Calcium & Vitamin D metabolism | ECE2018

Utility of contrast-enhanced ultrasound in preoperative evaluation of primary hyperparathyroidism

Ramirez Paola Parra , Marcos Patricia Martin Rojas , Hernando Antonio Santiago , Catalan Arturo Lisbona , Calvo Alejandro Casto , Escola Cristina Alvarez

Purpose: The aim of this study was to evaluate the sensitivy of contrast-enhanced ultrasound (CEUS) in the detection of pathological parathyroid gland in patients with primary hyperparathyroidism in comparison to the 99m-MIBI-SPECT scintigraphy.Methods: 29 patients consecutive (22 female, 7 male) with biochemically confirmed primary hyperparathyroidism, who underwent preoperative imaging with Technetium 99m-MIBI-SPECT scintigraphy and CEUS and subsequent...

ea0056p963 | Male Reproduction | ECE2018

Hypogonadism and mortality in type 2 diabetic men

Corrales Juan Jose , Herrero Ana , Caceres Rocio , Sanchez Ana Isabel , Marcos Miguel , Recio Jose Maria , Miralles Jose Manuel

Introduction: Low testosterone serum levels are associated with increased mortality in non-diabetic males. However, knowledge about the association between male hypogonadism and mortality among type 2 diabetic (T2DM) men is limited due to short follow-up periods in the few existing studies.Objective: To assess the association between hypogonadism and mortality in diabetic men.Material and methods: 263 unselected men with T2DM (mean...

ea0081ep372 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Follow-up gestational diabetes in a telemedicine system in pandemic COVID19

Delgado Garcia Esther , Perez Lopez Paloma , Sanchez Ibanez Marta , Nieto Maria , De Marcos White Lourdes , Santader Cartagena Amelia , de Luis Roman Daniel

Background: Gestational diabetes mellitus (GDM) is common complication in pregnancy. During pandemic COVID-19, endocrine service iniciate telemedicine in medical care and monitoring blood glucose.Purpose: The purpose of this study was to asses metabolic control and pregnancy outcome during pregnancy in telematic consult.Materials and Methods: Descriptive study of 20 patients were assesed in telematic review in the first wave of the...

ea0090ep1111 | Late Breaking | ECE2023

Maternally inherited diabetes and deafness (MIDD): easy to detect?

Fernandez Garcia-Salazar Rosario , Manjon-Miguelez Laura , Costales Marcos Maria , Burgueno Montanes Carmen , Santirso Rodriguez Daniel , Garcia Gonzalez Noelia , Menendez Torre Edelmiro

Introduction: Maternally inherited diabetes and deafness (MIDD) that is caused by a pathogenic variant in mitochondrial DNA (mtDNA) can cause different phenotypes based on percent heteroplasmy load, with higher mutation load corresponding with disease severity. The m.A3243G mutation causes either classic MELAS or MIDD that is a partial form. The condition is characterised by diabetes, hearing impairment and maculopathy but can have several other clinical manifestations. Early ...

ea0063p1116 | Pituitary and Neuroendocrinology 3 | ECE2019

Giant cerebral aneurysm a rare cause of hypopituitarism: a case report

Huerta Yolanda Zambrano , Marquez Pilar Olvera , Arranz Maria Teresa Herrera , Gonzalez Cristina Lorenzo , Fernandez Javier Garcia , Izquierdo Marcos Perera , Abizanda Enrique Palacio

Introduction: Hypophysary aneurysms are rare, they account for 1% to 2% of all intracranial aneurysms (1) and can be mistaken for pituitary adenomas, since they can have similar symptoms and even radiological signs especially if it’s an aneurysm completely thrombosed as angiography will show only avascular mass (2).Clinical case: A 84 year old female with past medical history of hypertension, dyslipidemia and depressive disorder, presents to emergen...